Phibro Animal Health | PAHC - Current Liabilities


Phibro Animal Health reported $281.87M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Align Technology USD 1.91B 14.16M Mar/2026
ANI Pharmaceuticals USD 239.51M 38.6M Mar/2026
Assertio Holdings USD 166.78M 34.25M Sep/2025
Aurora Cannabis CAD 145.94M 21.82M Dec/2025
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
Canopy Growth CAD 98.29M 17.19M Dec/2025
Corcept Therapeutics USD 149.18M 16.9M Mar/2026
Eli Lilly USD 36.63B 1.41B Mar/2026
Henry Schein USD 3.3B 69M Mar/2026
Idexx Laboratories USD 1.3B 151.04M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Merck USD 26.94B 1.38B Mar/2026
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Pacira USD 108.79M 11.8M Mar/2026
Phibro Animal Health USD 281.87M 500K Mar/2026
Prestige Brands USD 120.92M 18.63M Mar/2026
Supernus Pharmaceuticals USD 373.93M 35.76M Mar/2026
Zoetis USD 2.05B 182M Mar/2026